PDL BioPharma, Inc. News Releases http://investor.pdl.com/ PDL BioPharma, Inc. News Releases en PDL BioPharma to Participate at UBS Global Healthcare Conference http://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-participate-ubs-global-healthcare-conference INCLINE VILLAGE, Nev. , May 15, 2019 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that Dominique Monnet , PDL's president and chief executive officer, and Peter Garcia , PDL's chief financial officer, will present at the UBS Global Healthcare Conference in Wed, 15 May 2019 09:00:00 -0400 PDL BioPharma, Inc. News Releases 18521 PDL BioPharma Reports 2019 First Quarter Financial Results http://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-reports-2019-first-quarter-financial-results INCLINE VILLAGE, Nev. , May 9, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) reports financial results for the three months ended March 31, 2019 : First Quarter and Recent Financial Highlights Total revenues of $38.9 million . Thu, 09 May 2019 16:05:00 -0400 PDL BioPharma, Inc. News Releases 18501 PDL BioPharma to Announce First Quarter 2019 Financial Results on May 9, 2019 http://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-announce-first-quarter-2019-financial-results-may INCLINE VILLAGE, Nev. , May 2, 2019 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) today announced that it will release its first quarter 2019 financial results for the period ended March 31, 2019 , on Thursday, May 9, 2019 , after market close. Thu, 02 May 2019 09:00:00 -0400 PDL BioPharma, Inc. News Releases 18476 PDL BioPharma to Hold Annual Meeting of Stockholders on June 20, 2019 http://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-hold-annual-meeting-stockholders-june-20-2019 INCLINE VILLAGE, Nev. , April 16, 2019 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will hold its annual meeting of stockholders on Thursday, June 20, 2019 , at 3:00 p.m. Pacific Time for all stockholders of record on April 26, 2019 . Tue, 16 Apr 2019 16:05:00 -0400 PDL BioPharma, Inc. News Releases 18411 PDL BioPharma Announces Equity Investment in Evofem Biosciences http://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-announces-equity-investment-evofem-biosciences Transaction supports strategy of investing in near-commercial stage products with potential to create significant shareholder value Provides Evofem capital to prepare for the successful launch of Amphora® (L-lactic acid, citric acid, and potassium bitartrate), a novel, investigational non-hormonal, Thu, 11 Apr 2019 10:25:00 -0400 PDL BioPharma, Inc. News Releases 18401 PDL BioPharma to Participate at H.C. Wainwright & Co. Global Life Sciences Conference http://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-participate-hc-wainwright-co-global-life-sciences INCLINE VILLAGE, Nev. , March 26, 2019 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that Dominique Monnet , PDL's president and chief executive officer, and Peter Garcia , PDL's chief financial officer, will present at the H.C. Wainwright & Co. Tue, 26 Mar 2019 09:00:00 -0400 PDL BioPharma, Inc. News Releases 18346 PDL BioPharma Reports 2018 Fourth Quarter and Full Year Financial Results http://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-reports-2018-fourth-quarter-and-full-year INCLINE VILLAGE, Nev. , March 14, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) reports financial results for the three and 12 months ended December 31, 2018 : Financial Highlights Total revenues of $45.1 million for the 2018 fourth quarter and $198.1 million for Thu, 14 Mar 2019 16:05:00 -0400 PDL BioPharma, Inc. News Releases 18311 PDL BioPharma to Participate at 31st Annual Roth Conference http://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-participate-31st-annual-roth-conference INCLINE VILLAGE, Nev. , March 12, 2019 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that Peter Garcia , PDL's vice president and chief financial officer, will participate in a series of investor meetings at the 31 st Annual Roth Conference being held March Tue, 12 Mar 2019 09:00:00 -0400 PDL BioPharma, Inc. News Releases 18301 PDL BioPharma to Announce 2018 Fourth Quarter and Full Year Financial Results on March 14, 2019 http://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-announce-2018-fourth-quarter-and-full-year INCLINE VILLAGE, Nev. , March 7, 2019 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or "the Company") (NASDAQ: PDLI) today announced that it will release its 2018 fourth quarter and full year financial results for the period ended December 31, 2018 , on Thursday, March 14, 2019 , after market Thu, 07 Mar 2019 09:00:00 -0500 PDL BioPharma, Inc. News Releases 18286 PDL BioPharma to Participate at Cowen 39th Annual Health Care Conference http://investor.pdl.com/news-releases/news-release-details/pdl-biopharma-participate-cowen-39th-annual-health-care INCLINE VILLAGE, Nev. , March 5, 2019 /PRNewswire/ --  PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that Dominique Monnet , PDL's president and chief executive officer, and Peter Garcia , PDL's chief financial officer, will present at the Cowen 39 th Annual Health Care Tue, 05 Mar 2019 16:05:00 -0500 PDL BioPharma, Inc. News Releases 18281